Detalhe da pesquisa
1.
Combination of pembrolizumab and pelareorep promotes anti-tumour immunity in advanced pancreatic adenocarcinoma (PDAC).
Br J Cancer
; 129(5): 782-790, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37443348
2.
Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs.
Oncologist
; 28(1): 48-58, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36200844
3.
Paclitaxel With or Without Cixutumumab as Second-Line Treatment of Metastatic Esophageal or Gastroesophageal Junction Cancer: A Randomized Phase II ECOG-ACRIN Trial.
Oncologist
; 28(9): 827-e822, 2023 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37104870
4.
Phase III Prospectively Randomized Trial of Perioperative 5-FU After Curative Resection for Colon Cancer: An Intergroup Trial of the ECOG-ACRIN Cancer Research Group (E1292).
Ann Surg Oncol
; 30(2): 1099-1109, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305992
5.
NCCN Guidelines® Insights: Biliary Tract Cancers, Version 2.2023.
J Natl Compr Canc Netw
; 21(7): 694-704, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433432
6.
Anal Carcinoma, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(6): 653-677, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37308125
7.
Ampullary Adenocarcinoma, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 21(7): 753-782, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37433437
8.
Baseline Quality of Life is a Strong and Independent Prognostic Factor for Overall Survival in Metastatic Colorectal Cancer.
Cancer Control
; 30: 10732748231185047, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37339926
9.
Neoadjuvant therapy use and association with postoperative outcomes and overall survival in patients with extrahepatic cholangiocarcinoma.
J Surg Oncol
; 127(1): 90-98, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36194064
10.
Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance).
Oncologist
; 27(6): e494-e505, 2022 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35641198
11.
A phase II study of sapanisertib (TAK-228) a mTORC1/2 inhibitor in rapalog-resistant advanced pancreatic neuroendocrine tumors (PNET): ECOG-ACRIN EA2161.
Invest New Drugs
; 40(6): 1306-1314, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36264382
12.
Rectal Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 20(10): 1139-1167, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36240850
13.
Management of colorectal cancer during the COVID-19 pandemic: Recommendations from a statewide multidisciplinary cancer collaborative.
J Surg Oncol
; 125(4): 560-563, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34820843
14.
Use of Molecular Assays and Circulating Tumor DNA in Early-Stage Colorectal Cancer: A Roundtable Discussion of the Gastrointestinal Cancer Therapy Expert Group.
Oncologist
; 26(8): 651-659, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33650740
15.
Development of the Functional Assessment of Cancer Therapy-Carcinoid Syndrome Symptom Index.
Neuroendocrinology
; 111(9): 850-862, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-32911478
16.
Hepatobiliary Cancers, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(5): 541-565, 2021 May 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34030131
17.
Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(7): 839-868, 2021 07 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34340212
18.
Pancreatic Adenocarcinoma, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(4): 439-457, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33845462
19.
Colon Cancer, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 19(3): 329-359, 2021 03 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33724754
20.
Health-related quality of life in advanced gastric/gastroesophageal junction cancer with second-line pembrolizumab in KEYNOTE-061.
Gastric Cancer
; 24(6): 1330-1340, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34363528